Accelerate Diagnostics, Inc. Company Review & Valuation

AXDX
Nasdaq
Latest Price
3.75USD
Market Capitalization
261.24mUSD

About Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States.

It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast.

The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc.

in December 2012.

Accelerate Diagnostics, Inc.

was founded in 1982 and is headquartered in Tucson, Arizona.

Industry
Diagnostics & Research
HQ Location
Tucson, Arizona

Stock Price

Price data not available for Accelerate Diagnostics, Inc..

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top

Valuu.io

Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2019-2022 Valuu Analytics Sàrl